Editor ’ s Message: September –October 2016 Issue Highlights
Dear Colleagues:
Welcome to the September-October 2016 issue of Innovations in Clinical Neuroscience (ICNS). As the official journal of the CNS Summit, the International Society for CNS Drug Development (ISCDD), and the International Society for CNS Clinical Trials and Methodology (ISCTM), an important part of our editorial mission is to accelerate and enhance of the development of cheaper, more effective treatments for our patients through technology, collaboration, and innovation—not just in neuroscience but in all disciplines of medicine and among all involved entities, including clinicians, researchers, and members of industry. Building better clinical trials is crucial to developing better treatments, and in this issue of ICNS, we present examples of how technology, collaboration, and innovation can be used to improve two critical components of a successful clinical trial: patient adherence and symptom assessment. As practicing clinicians well know, adherence and assessment don’t stop with the clinical trial, so we hope clinicians and researchers alike will find value in the discoveries of this issue’s contributors.
We begin the issue with technology: In the article, “Performance, Reliability, Usability, and Safety of the ID-Cap System for Ingestion Event Monitoring in Healthy Volunteers: A Pilot Study,” Flores et al present the results of their study that evaluated an ingestible microsensor that is embedded in a medication capsule. Once activated by stomach fl...
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: ICN Online Editor Tags: Current Issue Drug Development Editor's Message: Issue Highlights Neurology Psychiatry Trial Methodology Amir H. Kalali CNS Summit Innovations in Clinical Neuroscience ISCDD ISCTM Source Type: research
More News: Anxiety | Bipolar | Brain | Clinical Trials | Dementia | Depression | Eszopiclone | Ischemic Stroke | Lunesta | Mania | Neurology | Pain | Pain Management | Psychiatry | Schizophrenia | Sertraline | Stroke | Study | Suicide | Zoloft